Advanced PET scans reveal that late-life depression and bipolar disorder may signal early neurodegenerative changes before dementia symptoms emerge.
Key Details
- 1Study involved 52 late-life mood disorder (LLMD) patients and 47 controls using PET imaging for tau and amyloid proteins.
- 2~50% of LLMD patients showed abnormal tau accumulation vs. 15% of controls; 29% had amyloid vs. 2% of controls.
- 3Autopsy of 208 brain cases confirmed higher tau-related pathologies in those with late-life mood symptoms.
- 4Pathological protein buildup detectable an average of 7.3 years before cognitive or motor symptoms.
- 5Study used two PET tracers to capture diverse tau and amyloid pathologies.
- 6Findings support tau-PET as a tool for early detection of neurodegenerative diseases in psychiatric populations.
Why It Matters
These findings advance the role of molecular PET imaging in diagnosing neurodegenerative diseases at the preclinical stage—especially in patients with mood disorders—enabling earlier interventions and reshaping the clinical approach to late-onset psychiatric presentations.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.